Pricing Log in Create free account

Insight Molecular Diagnostics Inc. (IMDX) vs Quantum Cyber N.V (QUCY)

Insight Molecular Diagnostics Inc. and Quantum Cyber N.V are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $80.5M against $60.8M — 1.3× the size. Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against −60.8%. Quantum Cyber N.V has the higher net margin (0.00% vs −2,955.6%) and the lower return on invested capital (−194.0% vs 0.00%). Across the 17 metrics below, Quantum Cyber N.V leads on 9 and Insight Molecular Diagnostics Inc. on 8.

Valuation

Metric IMDX QUCY Diagnostics & Research median
P/E n/m n/m 34.52
P/S 53.47 13.95 4.24
P/B n/m 0.62 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 42.95 0.78 5.18
Earnings yield (61.32%) (1,884.74%) (1.50%)
Free cash flow yield (34.71%) (132.86%) 0.00%

Profitability

Metric IMDX QUCY Diagnostics & Research median
Gross margin 48.32% 56.91% 48.32%
Operating margin (3,011.86%) 0.00% (5.68%)
Net margin (2,955.63%) 0.00% (4.10%)
Free cash flow margin (1,856.23%) 0.00% 0.00%
Return on equity 488.68% (325.19%) 0.00%
Return on assets (123.46%) (165.20%) (6.05%)
Return on invested capital 0.00% (193.99%) 0.00%

Growth

Metric IMDX QUCY Diagnostics & Research median
Revenue growth (TTM) (60.77%) 68.99% 8.99%
EPS growth (last fiscal year) 64.59% 87.92% 20.36%
Revenue growth, 5-year CAGR 27.24% 1.70% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX QUCY Diagnostics & Research median
Debt to equity (0.04) 0.00 0.01
Current ratio 2.00 5.56 2.27
Net debt to EBITDA (0.67) (0.01) 0.68

Dividend

Metric IMDX QUCY Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric IMDX QUCY Diagnostics & Research median
Market cap 80.50m 60.81m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack